How much revenue does BG Medicine make?

BG Medicine reported $1.57 million in revenue for fiscal year 2015, down 43.8% from $2.79 million in fiscal year 2014.

What companies are similar to BG Medicine?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Zecotek Photonics Inc. (ZMSPF), Xcorporeal, Inc. (XCRP), Motus GI Holdings, Inc. (MOTS), Imagin Medical Inc. (IMEXF).

BG Medicine, Inc. (BGMD) Stock

About BG Medicine, Inc.

BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as...

At a glance

BG Medicine reported revenue of $1.57 million for fiscal year 2015, down 43.8% from fiscal year 2014, and net income of -$6.96 million. Its market capitalization was $1,137 as of October 9, 2026.

Figures from company filings and market data; latest fiscal year ended December 31, 2015; market data as of October 9, 2026.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.